Image

ESMO 2021 - Immunotherapy, CDK4/6 inhibition ...
oncoXchange |

October 2021

Image

ESMO 2021 - Immunotherapy but not PARP inhibi ...
oncoXchange |

September 2021

Image

ASCO 2021 - Studies confirm utility of MammaP ...
oncoXchange |

June 2021

Image

ASCO 2021 - CDK4/6 inhibition maintains impro ...
oncoXchange |

June 2021

Image

SABCS 2020 - Immunotherapy knowledge in breas ...
oncoXchange |

December 2020

Image

SABCS 2020 - Personalized HER2 strategies ext ...
oncoXchange |

December 2020

Image

SABCS 2020 - COVID-19 aftermath its global di ...
oncoXchange |

December 2020

Image

SABCS 2020 - Identifying optimal adjuvant Rx ...
oncoXchange |

December 2020

Image

SABCS 2020 - Outcomes improving in TNBC with ...
oncoXchange |

December 2020

Image

Clinically meaningful survival advantage to a ...
oncoXchange |

September 2020